NASDAQ:NDRA ENDRA Life Sciences (NDRA) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free NDRA Stock Alerts $0.25 +0.01 (+4.22%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range$0.24▼$0.2550-Day Range$0.23▼$1.2152-Week Range$0.22▼$2.79Volume67,501 shsAverage Volume169,809 shsMarket Capitalization$2.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get ENDRA Life Sciences alerts: Email Address Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story About ENDRA Life Sciences Stock (NASDAQ:NDRA)ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.Read More NDRA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NDRA Stock News HeadlinesApril 12, 2024 | markets.businessinsider.comIRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in ColumbusApril 1, 2024 | finance.yahoo.comENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call TranscriptApril 19, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereMarch 29, 2024 | finance.yahoo.comQ4 2023 ENDRA Life Sciences Inc Earnings CallMarch 28, 2024 | businesswire.comENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 27, 2024 | benzinga.comEarnings Preview For ENDRA Life SciencesMarch 21, 2024 | finance.yahoo.comENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024March 14, 2024 | msn.comNuclera appoints Joseph Bertelsen as Chief Commercial OfficerApril 19, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereMarch 6, 2024 | bizjournals.comLife sciences companies need more than just scientistsFebruary 28, 2024 | msn.comENDRA installs first TAEUS liver system at London hospitalFebruary 27, 2024 | finance.yahoo.comENDRA Life Sciences Installs First TAEUS System in the UKFebruary 27, 2024 | businesswire.comENDRA Life Sciences Installs First TAEUS System in the UKFebruary 23, 2024 | msn.comNew findings suggest life span can be increased by making cells less efficient at producing energyFebruary 21, 2024 | finance.yahoo.comNew ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS SystemFebruary 21, 2024 | businesswire.comNew ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS SystemFebruary 21, 2024 | investing.comENDRA Life Sciences Inc (NDRA)February 17, 2024 | investing.comENDRA Life Sciences secures new patents for ultrasound techFebruary 15, 2024 | wsj.comENDRA Life Sciences Inc.February 14, 2024 | businesswire.comENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and EuropeFebruary 9, 2024 | msn.comNirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15February 6, 2024 | msn.comPanacea Life Sciences Strikes, Rescinds PUR Medical DealFebruary 4, 2024 | markets.businessinsider.comNurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. GrantDecember 10, 2023 | benzinga.comENDRA Life Sciences Stock (NASDAQ:NDRA) Dividends: History, Yield and DatesNovember 29, 2023 | finance.yahoo.comENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System TechnologyNovember 16, 2023 | msn.com$116 Million Life Sciences, Health Care, and Tech Innovation Hub Coming to Jersey CityNovember 15, 2023 | msn.comDallas-based company plans to resurrect prehistoric lifeSee More Headlines Receive NDRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today4/19/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:NDRA CUSIPN/A CIK1681682 Webwww.endrainc.com Phone(734) 335-0468FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.93) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,060,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-197.36% Return on Assets-144.22% Debt Debt-to-Equity RatioN/A Current Ratio6.26 Quick Ratio3.36 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.67 per share Price / Book0.36Miscellaneous Outstanding Shares11,040,000Free Float10,506,000Market Cap$2.70 million OptionableNot Optionable Beta0.98 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Francois Michelon (Age 58)Chairman, President & CEO Comp: $423.59kMr. Michael Thornton Ph.D. (Age 56)Chief Technology Officer Comp: $301.67kDr. Jonathan Behr Ph.D.Co-FounderMs. Irina Pestrikova (Age 37)Senior Director of Finance & Secretary Mr. Steve FreemanHuman Resources LeaderKey CompetitorsNuwellisNASDAQ:NUWETivic Health SystemsNASDAQ:TIVCHelius Medical TechnologiesNASDAQ:HSDTAtrecaNASDAQ:BCEL60 Degrees PharmaceuticalsNASDAQ:SXTPView All CompetitorsInsidersMichael Milos ThorntonBought 15,000 shares on 5/18/2023Total: $24,750.00 ($1.65/share)Anthony DigiandomenicoBought 83,333 shares on 5/2/2023Total: $99,999.60 ($1.20/share)View All Insider Transactions NDRA Stock Analysis - Frequently Asked Questions How have NDRA shares performed in 2024? ENDRA Life Sciences' stock was trading at $2.12 at the beginning of 2024. Since then, NDRA shares have decreased by 88.3% and is now trading at $0.2470. View the best growth stocks for 2024 here. Are investors shorting ENDRA Life Sciences? ENDRA Life Sciences saw a decline in short interest in March. As of March 31st, there was short interest totaling 30,600 shares, a decline of 36.9% from the March 15th total of 48,500 shares. Based on an average daily trading volume, of 170,700 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.3% of the company's shares are short sold. View ENDRA Life Sciences' Short Interest. When is ENDRA Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NDRA earnings forecast. How were ENDRA Life Sciences' earnings last quarter? ENDRA Life Sciences Inc. (NASDAQ:NDRA) announced its quarterly earnings data on Monday, November, 15th. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. During the same quarter in the prior year, the business earned ($0.15) earnings per share. What other stocks do shareholders of ENDRA Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Advanced Micro Devices (AMD), Trevena (TRVN), VBI Vaccines (VBIV), Bionano Genomics (BNGO), OPKO Health (OPK), TherapeuticsMD (TXMD), electroCore (ECOR) and Genocea Biosciences (GNCA). When did ENDRA Life Sciences IPO? ENDRA Life Sciences (NDRA) raised $10 million in an IPO on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO. How do I buy shares of ENDRA Life Sciences? Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NDRA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm PressThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.